OBSOLETE: Idiopathic severe pneumococcemia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:35065
Who is this for?
Show terms as
1FDA treatments8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

This entry in the Orphanet rare disease database is marked as 'OBSOLETE,' meaning it is no longer used as an active disease classification. It was previously listed under the name 'Idiopathic severe pneumococcemia,' which refers to a serious bloodstream infection caused by the bacterium Streptococcus pneumoniae (also called pneumococcus) that occurs without a clearly identified underlying cause or risk factor. In most cases, severe pneumococcal bloodstream infections happen in people who have a known reason for being vulnerable, such as a weakened immune system, a missing or non-functioning spleen, or certain chronic illnesses. When no such cause could be found, the infection was historically labeled 'idiopathic.' Over time, advances in immunology and genetics have revealed that many of these cases are actually linked to subtle immune deficiencies or genetic variants that were previously undetectable. As a result, this diagnostic category has been retired and replaced by more precise diagnoses. If you or a loved one received this label, a specialist in immunology or infectious disease can help identify the true underlying cause and guide appropriate care.

Key symptoms:

High fever and chillsRapid or difficult breathingSevere headacheStiff neckConfusion or altered mental stateExtreme fatigue and weaknessLow blood pressure or signs of shockSkin rash or discoloration in severe casesNausea and vomiting

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

1 available

Lantidra

donislecel-jujn· CellTrans Inc.
indicated for the treatment of adults with Type 1 diabetes who are unable to approach target HbA1c because of current repeated episodes of severe hypoglycemia despite intensive diabetes management and

indicated for the treatment of adults with Type 1 diabetes who are unable to approach target HbA1c because of current repeated episodes of severe hypoglycemia despite intensive diabetes management and education

No actively recruiting trials found for OBSOLETE: Idiopathic severe pneumococcemia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Idiopathic severe pneumococcemia community →

No specialists are currently listed for OBSOLETE: Idiopathic severe pneumococcemia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Idiopathic severe pneumococcemia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Idiopathic severe pneumococcemiaForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Idiopathic severe pneumococcemia.

Start the conversation →

Latest news about OBSOLETE: Idiopathic severe pneumococcemia

No recent news articles for OBSOLETE: Idiopathic severe pneumococcemia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Since this diagnosis is now considered obsolete, what is the current best explanation for why this infection happened?,Should I be tested for an underlying immune deficiency or genetic condition?,What vaccinations do I need to reduce my risk of future pneumococcal infections?,Do I need long-term preventive antibiotics or other ongoing treatment?,Should my close family members be evaluated for a similar underlying condition?,What warning signs should prompt me to go to the emergency room immediately?,Which specialist should be leading my long-term care going forward?

Common questions about OBSOLETE: Idiopathic severe pneumococcemia

What is OBSOLETE: Idiopathic severe pneumococcemia?

This entry in the Orphanet rare disease database is marked as 'OBSOLETE,' meaning it is no longer used as an active disease classification. It was previously listed under the name 'Idiopathic severe pneumococcemia,' which refers to a serious bloodstream infection caused by the bacterium Streptococcus pneumoniae (also called pneumococcus) that occurs without a clearly identified underlying cause or risk factor. In most cases, severe pneumococcal bloodstream infections happen in people who have a known reason for being vulnerable, such as a weakened immune system, a missing or non-functioning sp

What treatment and support options exist for OBSOLETE: Idiopathic severe pneumococcemia?

1 patient support program are currently tracked on UniteRare for OBSOLETE: Idiopathic severe pneumococcemia. See the treatments and support programs sections for copay assistance, eligibility, and contact details.